Mariner
EDIT icon

Mariner’s Editas Medicine EDIT Stock Holding History

Mariner’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$549K Buy
169,291
+23,751
+16% +$69.4K ﹤0.01% 2388
2026
Q1 		$359K Buy
145,540
+104,219
+252% +$221K ﹤0.01% 2717
2025
Q4 		$84.7K Sell
41,321
-36,094
-47% -$104K ﹤0.01% 3355
2025
Q3 		$269K Buy
77,415
+23,675
+44% +$66.1K ﹤0.01% 2912
2025
Q2 		$118K Buy
53,740
+31,959
+147% +$52.3K ﹤0.01% 3203
2025
Q1 		$25.3K Buy
+21,781
New +$32K ﹤0.01% 3357
2024
Q4 		– Sell
-11,554
Closed -$39.4K – 3418
2024
Q3 		$39.4K Buy
+11,554
New +$50.3K ﹤0.01% 3213
2024
Q2 		– Sell
-16,389
Closed -$122K – 3207
2024
Q1 		$122K Buy
+16,389
New +$136K ﹤0.01% 2893

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mariner's EDIT Position: Q2 2026 in Review

Mariner increased its Editas Medicine (EDIT) stake by 16% in Q2 2026, buying an estimated $69.4K and bringing the position to 169,291 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Mariner first reported a position in EDIT in Q1 2024 and has held it in 8 quarters since. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Mariner held 169,291 shares of Editas Medicine worth $549K as of Q2 2026.
  • Mariner bought 23,751 Editas Medicine shares in Q2 2026, an estimated $69.4K.
  • Editas Medicine made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2388 holding.
  • Mariner first reported a position in Editas Medicine in Q1 2024 and has held it in 8 quarters since.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.